Publication Name	World Journal of Clinical Cases
Manuscript ID	62890
Country	France

Received	2021-08-11 14:27
Peer-Review Started	2021-08-11 14:30
To Make the First Decision
Return for Revision	2021-09-02 01:09
Revised	2021-09-23 15:29
Second Decision	2022-02-08 06:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-02-10 10:38
Articles in Press	2022-02-10 10:38
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-01-20 10:49
Typeset the Manuscript	2022-02-19 17:51
Publish the Manuscript Online	2022-03-11 00:39

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Case Report
Article Title	Escitalopram-induced hepatitis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Guillaume Wabont, Laurie Ferret, Nicolas Houdre, Antoine Lepied, Johana Bene and Etienne Cousein
ORCID	Author(s) ORCID Number Guillaume Wabont http://orcid.org/0000-0002-2594-0993 Laurie Ferret http://orcid.org/0000-0002-7338-1014 Nicolas Houdre http://orcid.org/0000-0003-2023-0594 Antoine Lepied http://orcid.org/0000-0002-6935-0856 Johana Bene http://orcid.org/0000-0002-1137-1830 Etienne Cousein http://orcid.org/0000-0003-1875-3273
Funding Agency and Grant Number
Corresponding Author	Guillaume Wabont, PharmD, Pharmacist, Statistician, Department of Pharmacy, Valenciennes Hospital, Avenue Desandrouin, Valenciennes 59300, France. wabont.guillaume@gmail.com
Key Words	Escitalopram; Hepatitis; Cholestasis; Pharmacovigilance; Case report
Core Tip	The antidepressant escitalopram is widely prescribed for the treatment of depression. The article consists of a unique clinical case, a review of the literature and a pharmacovigilance analysis. This is the first clinical case of escitalopram as the only possible drug causing hepatitis and cholestasis. This is also the first pharmacovigilance analysis conducted to qualify and quantify the risk of hepatitis and cholestasis when using escitalopram.
Publish Date	2022-03-11 00:39
Citation	Wabont G, Ferret L, Houdre N, Lepied A, Bene J, Cousein E. Escitalopram-induced hepatitis: A case report. World J Clin Cases 2022; 10(8): 2468-2473
URL	https://www.wjgnet.com/2307-8960/full/v10/i8/2468.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i8.2468

Full Article (PDF)	WJCC-10-2468.pdf
Full Article (Word)	WJCC-10-2468.docx
Manuscript File	62890_Auto_Edited-JJW-Webster J.docx
Answering Reviewers	62890-Answering reviewers.pdf
Audio Core Tip	62890-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	62890-Conflict-of-interest statement.pdf
Copyright License Agreement	62890-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	62890-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	62890-Language certificate.pdf
Supplementary Material	62890-Supplementary material.pdf
Peer-review Report	62890-Peer-review(s).pdf
Scientific Misconduct Check	62890-Bing-Wang JJ-2.png
Scientific Editor Work List	62890-Scientific editor work list.pdf